In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA
Launched by THE UNIVERSITY OF TENNESSEE, KNOXVILLE · Sep 23, 2019
Trial Information
Current as of November 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well two types of knee implants—the MicroPort Medial Pivot and DePuy Attune posterior cruciate retaining (PCR) total knee arthroplasties—perform in real-life movement. Researchers want to understand how these implants work while people go about their daily activities, such as stepping up and doing deep knee bends. Dr. Russell Nevins from the Nevada Orthopedic & Spine Center will lead this study, which is looking for participants who are at least 6 months post-surgery and have had one of the two knee implants mentioned.
To be eligible for this study, participants should be between the ages of 65 to 74 and must have been evaluated as successful in their recovery by their surgeon. They should also be able to complete certain movements and be willing to sign a consent form to join the study. However, people who are pregnant, do not have one of the specified knee implants, cannot perform the required activities, or do not speak English will not be able to participate. The trial is currently not recruiting, but if you meet the criteria, it could be an opportunity to help researchers learn more about knee implants and their effectiveness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects will have either a MicroPort Medial Pivot or DePuy Attune PCR TKA.
- • Subjects must be at least six months post-operative.
- • Participants must be judged clinically successful based on the surgeon's evaluation and their Forgotten Knee Score.
- • Participants must be able to perform the required activities - stepping up and a deep knee bend.
- • Subjects must be willing to sign the Informed Consent (IC) / HIPAA form to participate in the study
- Exclusion Criteria:
- • Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study.
- • Subjects without one of the two types of knee implants under investigation.
- • Subjects who are unable to perform stepping up and deep knee bend.
- • Subjects who are unwilling to sign Informed Consent/ HIPAA documents.
- • Does not speak English.
About The University Of Tennessee, Knoxville
The University of Tennessee, Knoxville, is a prestigious public research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at improving patient outcomes and contributing to the scientific community. Its state-of-the-art facilities and commitment to ethical research practices ensure rigorous study design and execution, positioning the university as a leader in clinical research and a valuable partner in the quest for medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Knoxville, Tennessee, United States
Patients applied
Trial Officials
Richard Komistek, Ph.D.
Principal Investigator
The University of Tennessee
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials